COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials

By sjmartinez • April 11, 2024

Sherman A, Tuan J, Cantos VD, Adeyiga O, Mahoney S, Ortega-Villa AM, Tillman A, Whitaker J, Woodward Davis AS, Leav B, Hirsch I, Sadoff J, Dunkle LM, Gilbert PB, Janes HE, Kublin JG, Goepfert PA, Kotloff K, Rouphael N, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Nason M, Baden LR, Gay CL. COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials. Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093/cid/ciae192. Epub ahead of print. PMID: 38598658.

Tags: covid-19, HIV, immunocompromised, Infectious Diseases, Publications, vaccine, vaccine efficacy

Inhibition of Candida albicans yeast-to-hypha transition and virulence by cyclic dipeptides derived from probiotic Aeromonas veronii V03

Sekar J, Parasuraman G, Shanmugam A, Dharumadurai D, Dileep Kumar BS, Natesan S. Inhibition of Candida albicans yeast-to-hypha transition and virulence by cyclic dipeptides derived[...]

Factors influencing implementation of point-of-care tests for maternal and newborn screening and diagnosis in low-resource settings: a systematic review

Shaetonhodi NG, de Vos L, Brock P, Davey DJ, de Voux A, Medina-Marino A. Factors influencing implementation of point-of-care tests for maternal and newborn screening[...]

West Nile Morbidity and Mortality in a Mid-Atlantic Health Care System, 2013-2024

Judson SD, Auwaerter P, Dowdy D. West Nile Morbidity and Mortality in a Mid-Atlantic Health Care System, 2013-2024. Am J Trop Med Hyg. 2026 Apr[...]